Sequence Personal (www.sequencepartners.com), an innovative provider of proprietary software that enables readers to select relevant content to be digitally produced as specialized publications, has been sold to R. R. Donnelley & Sons Company (NASDAQ: RRD) (www.rrdonnelley.com).  Focused originally on the creation of individualized medical journals with targeted advertising, Sequence’s technologies have expanded to enable custom publishing across a broad variety of verticals. For example, its ANTHOLOGY offering provides consumers a wide array of choices for individualizing content. Publishers and other organizations can take advantage of Sequence’s applications to increase revenues by allowing advertisers to select unique ad selection criteria for more targeted delivery.

“Understanding that personalization was becoming increasingly important to the way media is consumed, Sequence and the ANTHOLOGY platform were created as a way for the industry to participate in this trend and help usher in the next generation of publishing,” said Charles Benaiah, Founder of Sequence Personal.

JEGI represented Sequence Personal in this transaction and acted as its exclusive financial advisor.  For more information, click here.